Skye Bioscience Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.08

+0.00 (+0.00%)

As of Nov 14, 2:41 AM ET ·

Analyst Consensus

Buy

Analysts

Moderate

Coverage

Buy 7 70%

Hold 3 30%

Sell 0 0%

Price Target

Analyst Price Target +1,372.2% upside

Low Target $11.92

Average Target $15.90

High Target $19.90

Current Price $1.08

Current
$1.08

Target
$15.90

$11.92 $15.90 avg $19.90

Scenario Analysis

Bear Case

$11.92

1,003.7%

Low target

Base Case

$15.90

+1,372.2%

Avg target

Bull Case

$19.90

+1,742.6%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$12.72

-91.5% from high

52-Week Low

$0.50

+116.0% from low

Target vs 52W High

$15.90

+25.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.7%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.6%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-92.0%
MRNA Moderna Inc	Hold	31	32%	$149.45	-33.1%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.2%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-33.8%